A global virtual event dedicated to the latest heart failure treatment strategies to support better patient outcomes

Overview

Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to announce the return of e-SPACE Heart Failure to be held 18-19 October 2024.

Last year’s event brought together over 50 leading experts from across the globe, drawing a live international audience of thousands. Click here to watch e-SPACE Heart Failure 2023 on-demand.

e-SPACE Heart Failure 2024 will once again provide top-tier free virtual education and will both optimise geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme will explore how leading experts are incorporating heart failure guidelines into clinical practice and will offer the latest information on patient profiling in heart failure for tailored medical therapy.

Building on the tremendous success of previous years, this event will once again bring together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

Underpinned by this combined expertise in educational content and delivery, and led by an international faculty of global standing, e-SPACE Heart Failure 2024 is designed to support you in achieving optimal clinical outcomes in heart failure management.

Programme

(Please note this programme is subject to change)

Day 1

9:00 AM - 10:00 AM (BST)
Plenary Session
Session 1 – Practical implementation of GDMT in the clinical setting

  • Physicians perceptions towards implementing GDMT in HF – Gianluigi Savarese

  • Contemporary GDMT sequencing and titration

  • Dietary sodium and fluid intake in HF

  • Panel discussion



10:10 AM - 10:50 AM (BST)
Meet the Expert
Meet the Expert

11:00 AM - 12:00 PM (BST)
Plenary Session
Session 2 – SGLT2s in clinical practice

  • SGLT2 in post MI HF – Javed Butler

  • SGLT2 inhibitors early initiation – Clara Inés Saldarriaga

  • SGLT2 and cardiorenal protection – Faiez Zannad

  • Panel discussion



1:20 PM - 1:50 PM (BST)
Meet the Expert
Meet the Expert

2:00 PM - 3:00 PM (BST)
Plenary Session
Session 3 – Obesity and weight management in HF

ChairsStefan Anker and Alice Cheng

  • Obesity and HF: epidemiology and mechanisms – Naveed Sattar

  • Weight management in HFpEF – Shelley Zieroth

  • Overview of current therapeutic agents – Milton Packer

  • The role of GLP-1RA and HF – Peter Rossing

  • Panel discussion



3:10 PM - 3:50 PM (BST)
Meet the Expert
Meet the Expert

4:00 PM - 5:00 PM (BST)
Plenary Session
Session 4 – Managing cardiomyopathy in HF

ChairMichelle Kittleson

  • Epidemiology and clinical features – Arnt Kristen

  • Differential diagnosis – Michelle Kittleson

  • Management of cardiac amyloidosis – Mariana Fontana

  • New approaches in the management of HCM

  • Panel discussion



6:20 PM - 6:50 PM (BST)
Meet the Expert
Meet the Expert

7:00 PM - 8:00 PM (BST)
Plenary Session
Session 5 – Cardiac rhythm in HF

ChairAndrea Russo

  • The role of CRM devices in HF – Klaus Witte

  • Prevention of sudden arrhythmic death in HFrEF

  • CRT in HFrEF for whom and when

  • A modular communicative leadless pacing-defibrillator system

  • Panel discussion



9:00 PM - 10:00 PM (BST)
Plenary Session
Session 6 – Devices in HF; time to reassess their place?

  • Neuromodulation therapy for HFrEF

  • CCM: benefits of early implementation – Marat Fudim

  • Interatrial shunts

  • Sleep apnea

  • Panel discussion




Day 2

9:00 AM - 10:00 AM (BST)
Plenary Session
Session 7 – Enabling GDMT in HF

  • Unmet needs in guidelines implementation

  • The role of potassium binders – Gianluigi Savarese

  • Non-steroidal MRAs – Gerasimos Filippatos

  • The role of SGLT2i in preventing hyperkalemia – Joao Ferreira

  • Panel discussion



10:10 AM - 10:50 AM (BST)
Meet the Expert
Meet the Expert

11:00 AM - 12:00 PM (BST)
Plenary Session
Session 8 – Iron deficiency: the totality of evidence

  • Iron deficiency in HFrEF – Ewa Jankowska

  • Latest data on ferric derisomaltose

  • How to keep to the diagnosis simple?

  • Panel discussion



2:00 PM - 3:00 PM (BST)
Plenary Session
Session 9 – Managing HFpEF in 2024

  • The role of non-steroidal MRAs

  • The effect of iron on patients with HFpEF – Stefan Anker

  • The potential role of interleukin-6 (IL-6) antibodies in HFpEF – Mark Petrie

  • Panel discussion



3:10 PM - 3:50 PM (BST)
Meet the Expert
Meet the Expert

4:00 PM - 5:00 PM (BST)
Plenary Session
Session 10 – Valvular heart disease

  • Drugs and interventions in HF – Marianna Adamo

  • Targeting FMR – Stefan Anker

  • Management of TR in HF – Karl Kresoja

  • Panel discussion



6:20 PM - 6:50 PM (BST)
Meet the Expert
Meet the Expert

7:00 PM - 8:00 PM (BST)
Plenary Session
Session 11 – Remote monitoring and team approaches in the management of HF

ChairMaria Rosa Costanzo

  • Latest experience with haemodynamic monitoring – JoAnn Lindenfeld

  • Evaluating accelerated guideline-directed medical therapy for HF (TEAM-HF)

  • Reveal Linq – Javed Butler

  • Voice recognition – Offer Amir

  • Panel discussion



9:00 PM - 10:00 PM (BST)
Plenary Session
Replay of previous session


Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com